DALLAS, Feb. 13, 2025 /PRNewswire/ — Koning Health is proud to announce the grand opening of The Painless Mammogram clinic in Dallas, led by breast imaging expert and Koning Health’s Co-Chief Medical Officer, Dr. Richard Reaven. The new clinic brings groundbreaking advancements in breast cancer imaging technology to the heart of Texas, offering patients a revolutionary alternative to traditional mammograms.
The Painless Mammogram clinic features the Koning Vera, an innovative breast imaging system that delivers unparalleled 3D imaging quality while eliminating the discomfort associated with traditional compression-based mammography. Designed to enhance early detection and improve the patient experience, the Vera Scan leverages advanced Cone Beam CT technology, providing radiologists with detailed and accurate images that aid in the detection of breast cancer at its earliest stages.
“This clinic represents a paradigm shift in breast cancer imaging,” said Dr. Reaven. “With the Koning Vera, we can prioritize both accuracy and patient comfort, making routine breast imaging a more accessible and less intimidating experience for women. Our mission is to redefine the standard of care in breast imaging.”
The Dallas location is the first of its kind in the region, offering:
The clinic’s opening comes at a pivotal moment as breast cancer remains one of the most prevalent cancers affecting women worldwide. By providing a cutting-edge, pain-free option for imaging, the Painless Mammogram clinic is poised to make a significant impact on early detection rates and patient outcomes.
For more information about the Painless Mammogram clinic and to schedule an appointment, visit https://thepainlessmammogram.com/.
About Koning: Koning is a global Health Technology company focused on improving the breast imaging industry with its patented Koning Vera Breast CT (KBCT). Koning’s vision is to create a revolution in medical imaging through advanced computed tomography technology that dramatically improves the way clinicians visualize and evaluate breast tissue. The Koning Vera is expected to optimize early disease detection, diagnosis, intervention, and treatment, and will improve survival rates for millions of patients worldwide. For more information, please visit Koning’s website or email Koning at info@koningcorporation.com.
SOURCE KONING CORPORATION
PLEASANTON, Calif., April 14, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell…
MOORPARK, Calif., April 14, 2025 /PRNewswire/ -- Lifetech Resources is proud to announce that its…
CHICAGO, April 14, 2025 /PRNewswire/ -- BlackDoctor.org (BDO), the nation's leading health and wellness destination…
RESTON, Va., April 14, 2025 /PRNewswire/ -- The theoretical radiation risk proposed by Smith-Bindman, et…
BORDEAUX, France & BOSTON--(BUSINESS WIRE)--Regulatory News: IMPLANET (Euronext Growth : ALIMP, FR0013470168, éligible PEA-PME), a…
iHarbor recognized for Gallion, a cloud-based supply chain management solution developed at UMMS BALTIMORE--(BUSINESS WIRE)--The…